Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs

One of the most controversial issues among rheumatologists is the best approach to managing a rheumatic patient (RP) with coronavirus disease 2019 (COVID-19). This study aims to evaluate the prevalence of COVID-19 in RPs compared to the general population and to relatively assess the potential role...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradi, Soroush, Masoumi, Maryam, Mohammadi, Somayeh, Vafaeimanesh, Jamshid, Mohseni, Mohaddeseh, Mahdavi, Hossein, Aryannejad, Armin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Im - Original
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599976/
https://www.ncbi.nlm.nih.gov/pubmed/33128696
http://dx.doi.org/10.1007/s11739-020-02535-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599976/
https://www.ncbi.nlm.nih.gov/pubmed/33128696
http://dx.doi.org/10.1007/s11739-020-02535-5

Ejemplares similares